Advisory Team

The Advisory Team at Chameleon Biosciences provides strategic guidance and expert insights to advance the development and regulatory approval of EVADER™, the company's innovative AAV-based gene therapy platform. Comprising experienced professionals in clinical, regulatory, and industry domains, the team ensures that the company's efforts align with its mission to deliver life-changing, re-dosable gene therapies for previously untreatable conditions.